Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

http://www.ligand.com


LGND $124.86 -4.31 (-3.34%)
Sector Health Care
Industry Biotech & Pharma
Market Cap 2.55 Billion
EPS -2.00 P/E Ratio 20.75
Previous Earnings Mon, Aug 6, 2018
Latest Earnings Thu, Nov 8, 2018
Dividend --
Ex-Date --
Dividend Pay Date --
Dividend History --

124.86 2.55 20.75 0.00 LGND NASDAQ -3.34 -8.86 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LGND&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LGND&exchange=NASDAQ&chart=1

Symbol Surfing has been referenced on Barrons, CNN & Investor Place.

About | Blog | Advertising | Terms | info@symbolsurfing.com

Investing Quotes #Legendary


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.

©2019 Symbol Surfing All Rights Reserved. Privacy Policy | ^Top